The Food and Drug Administration found trace amounts of asbestos in Johnson & Johnson baby powder. J&J is recalling 33,000 bottles of baby powder in the U.S. The company is facing thousands of lawsuits claiming that the baby powder has caused cancer. (Reuters)

House Speaker Nancy Pelosi’s drug pricing bill passed a House committee. The House Energy and Commerce Committee advanced the sweeping bill. It has to move through two committees before going to a floor vote. (CNBC)

Sanofi recalled Zantac due to traces of a possible carcinogen. Last month, some pharmacies such as CVS stopped stocking Zantac after the FDA issued an alert about a cancer-causing chemical found in the medicine. (New York Times)

Lawmakers are pressuring the FDA to address shortages of the Takeda thyroid drug after recall. Takeda recalled the drug, Natpara, last month after learning that rubber particles may clog the needles of its cartridges. Lawmakers, including Sen. Bernie Sanders (I-VT), want the FDA to take action on the resulting shortage. (STAT)

After success in epilepsy, GW Pharmaceuticals is looking to apply its CBD drug to other conditions. The company is looking into CBD as a treatment for conditions from multiple sclerosis to autism. Many with these conditions already use CBD supplements to control symptoms. (STAT)